论文部分内容阅读
在帕金森病(Ｐａｒｋｉｎｓｏｎｓｄｉｓｅａｓｅ,ＰＤ)长期治疗中常会出现运动波动(剂末现象和开关现象)和异常的不自主运动(异动症和肌张力障碍)。Ｊｕｍｅｘ(Ｓｅｌｅｇｉｌｉｎｅ,Ｌｄｅｐｒｅｎｙｌ)是一种选择性不可逆的单胺氧化酶Ｂ(ＭＡＯＢ)抑制剂。动物实验表明,它能
In the long-term treatment of Parkinson’s disease (Parkinson’s disease, PD) often appear movement fluctuations (end phenomenon and switch phenomenon) and abnormal involuntary movements (dyskinesias and dystonia). Jumex (Selegiline, Ldeprenyl) is a selectively irreversible monoamine oxidase B (MAOB) inhibitor. Animal experiments show that it can